LifeGuide

Better Days A new study looks at changes in mood as they relate to risk & protection by Chael Needle "Happy” is not just a number-one song...

Step by Step At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation by Jeannie Wraight This year marked the 24th annual Conference on Retroviruses...

One Drug, Many Possibilities A new agent may assist in the fight against HIV and other viruses by Jeannie Wraight Every once in a while I come...

In February, Swedish Medical Center in Englewood, Colorado, revealed that it told nearly 3,000 former surgery patients that they should get tested for hepatitis...

Hep Talk by Larry Buhl The War on Common Sense A new report advocates decriminalizing drug use to reduce Hep C The so-called “war on drugs” is...

While potent new direct-acting antiviral (DAA) therapy has revolutionized treatment hepatitis C by shortening treatment and offering an actual cure, there has been one...

LifeGuide HCV testing targets baseball lovers by Larry Buhl This summer a pilot program was launched to raise awareness of the importance of testing for the hepatitis...

LifeGuide Two Birds, One Stone Researchers make advances with agents that can target dual points of entry by Mariel Selbovitz, MPH Drug discovery and early to mid-stage drug...

Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes...

Hiding Place One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs by Jeannie Wraight This year, amfAR marked World AIDS Day with the 2016 HIV...